Program Supplement [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Y1~j~

LB02 Late Breaker
Late Breaker Oral Abstract Session
Venue: Hall 5:7
Date: Thursday, July 11, 200oo2
Time: 16:oo - 17:3o0
Chairs: Constance Benson, United States
Robert Muga, Spain
16:oo LbOro9 Earlier initiation of HAART better preserves
functional immune competence even in
persons who achieve "normal" CD4+ T-cell
counts
Christoph Lange, Hernan Valdez, Kathy
Medvik, Robert Asaad, Mary Wild, Robert
Kalayjian, Michael Lederman
(United States)
16:11 LbOrio Development of genetically protected Tlymphocytes from transduced hematopoietic
progenitors in human immunodeficiency
virus-1 infected patients
Rafael Amado1, Ronald Mitsuyasu, Joseph
Rosenblatt1, Frances Ngok, Andreas
Bakker', Steve Cole1, Nathalie Chorn, LiiShin Lin', Gregory Bristol, Steven
Miles, Maureen Boyd2, Janet
MacPherson2, Gregory Fanning2, Alison
Todd2, Julie Ely2, Jerome Zack1, Geoff
Symonds2 1United States; 2Australia)

16:44 LbOrl3

16:55 LbOrl4
17:o6 LbOr15
17:17 LbOri6

Preliminary analysis of a randomised
controlled study to assess the role of postexposure prophylaxis in reducing mother to
child transmission of HIV-1
Glenda Gray, Mike Urban, Avye
Violari, Matthew Chersich, Ronelle van
Niekerk, James McIntyre (South Africa)
Cytotoxic T lymphocyte responses in
participants enrolled in a phase 1/11
canarypox (ALVAC)/ gpl2o B/E prime-boost
HIV vaccine trial in Thailand
Mark de Souza', Chitraporn
Karnasuta, Josephine Cox2, Sorachai
Nitayaphan', Punnee
Pittisituttithum', Arthur Brown, Sanjay
Gurunathan2, William Heyward2, John
McNei, Deborah Birx (Thailand; 2United
States)
Hepatic safety of nevirapine: results of the
Boehringer Ingelheim Viramune~ Hepatic
Safety Project
Jerry Stern, Stephan Lanes, James
Love, Patrick Robinson, Michael
Imperiale, Douglas Movayers (United States)
RIBAVIC trial (ANRS HC02): a controlled
randomized trial of pegylated-interferon
alfa-2b plus ribavirin vs interferon alfa-2b
plus ribavirin for the initial treatment of
chronic hepatitis C in HIV co-infected
patients: preliminary results
Christian Perronne Fabrice Carrat, Firouze
Bani Sadr, Thidaravy Hor, Patrice
Morand, Francoise Lunel, Eric
Rosenthal, Stanislas Pol, Patrice Cacoub,
For the ANRS HC02 Study group (France)

16:22 LbOril
16:33 LbOrl2

Safety, immunogenicity and antiviral efficacy
of a new topical DNA vaccine in macaques
with chronic infection and AIDS
Julianna Lisziewicz, Jianqing Xu, Mark
Lewis, Jeffrey Trocio, Lucia Whitman, Franco
Lori (United States)
Strong CD4+ T cell responses to HIV
antigens in treated patients is not predictive
of restriction of viral replication
John Tilton, Christiana lyasere, Stephen
Migueles, Alisha Laborico, Mark Connors
(United States)

XIV International AIDS Conference BARCELONA - JULY 7-12

13